Labcorp Holdings (LH) Stock Analysis & Winston Score
Labcorp is one of the largest medical testing companies in the United States. It collects blood, urine, and tissue samples from patients and runs laboratory tests that help doctors diagnose diseases, monitor health conditions, and guide treatment decisions. The company serves patients, hospitals, physician offices, and pharmaceutical companies across a wide range of testing needs, from routine blood work to complex genetic analysis. Labcorp makes money by charging fees for each test it performs, with payments coming from insurance companies, government programs like Medicare and Medicaid, and patients directly. It operates thousands of patient service centers and labs primarily across the U.S., with some international presence, and processes hundreds of millions of tests each year. Its scale and established network of collection sites give it a cost advantage over smaller competitors. The main risk the company faces is ongoing pressure from insurers and government payers to lower reimbursement rates, which can squeeze profit margins over time.
Winston Score: 51/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (9/30)
- Growth: Exceptional (18/20)
- Cash Flow: Strong (8/10)
- Stability: Good (6/10)
- Valuation: Strong (7/10)
- Ownership: Weak (2/15)


